University of Minnesota: Cystic Fibrosis trials
The registry lists 14 Cystic Fibrosis studies with University of Minnesota as lead sponsor. 1 are open to participants now and 5 have results posted.
Phase 1 1Phase 2 4Phase 3 4Phase 4 1No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding MothersNot yet recruitingNCT04940533
- SGLT2 Inhibitor Therapy in Cystic Fibrosis-related DiabetesActive, not recruitingNCT06149793Phase 2/3Results posted
- Semaglutide in CFRDCompletedNCT05788965Phase 2/3Results posted
- The Role of Oral Glutathione on Growth Parameters in Children With Cystic FibrosisCompletedNCT03020719Phase 2Results posted
- The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis PatientsTerminatedNCT02496780Phase 2/3Results posted
- Comparison of Airway Clearance Therapy in Cystic Fibrosis Using the Same VEST Therapy Device But With Different SettingsCompletedNCT00685035Phase 4Results posted
- Cystic Fibrosis and Cognitive FunctionCompletedNCT03820349
- The Sinonasal Cavity as a Reservoir for Upper Airway Bacterial DevelopmentCompletedNCT03016689
- Mapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung SpecimensCompletedNCT02128711
- Biomarkers of Injury and Destruction in the Cystic Fibrosis LungCompletedNCT01805713
- A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.TerminatedNCT00332215Phase 1
- Comparison of Airway Clearance Efficacy of Two High Frequency Chest Wall Oscillation (HFCWO) Devices in Cystic FibrosisCompletedNCT00308958Not applicable
- Insulin Glargine Vs Standard Insulin TherapyCompletedNCT00222521Phase 3
- The Microvascular Complications StudyCompletedNCT00222508